Nuvalent
Kanan B. is an experienced medical professional currently serving as Senior Medical Director at Nuvalent, Inc. since April 2024 and at Deciphera Pharmaceuticals since July 2022. Previously, Kanan held the position of Medical Director, Safety Sciences at Nektar Therapeutics from November 2021 to November 2022 and held various roles at Medpace from June 2017 to November 2021, including Safety Physician and Senior Clinical Safety Manager. Prior to that, Kanan worked as a Senior Case Evaluator at Bayer HealthCare from October 2014 to October 2016 and as a Medical Device Lead and BARC Lead at Merck between January 2012 and October 2014, also serving as a PV Drug Safety Physician Specialist. Kanan B. earned a degree from JSS Medical College in Mysore.
This person is not in any teams
This person is not in any offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.